Ellen Strahlman Joins Altria Board

Source from:  Tobacco reporter 10/29/2020

Ellen R. Strahlman will join the Altria Group board of directors Nov. 2, 2020, the company announced in a press release.

Strahlman served as executive vice president, research & development and chief medical officer of Becton, Dickinson and Co., a leading global medical technology company, from April 2013 until her retirement in January 2018.

Before joining Becton Dickinson and Co., she served as a senior advisor to the CEO at GlaxoSmithKline from April 2012 through March 2013, after previously serving as the senior vice president and chief medical officer from April 2008 through March 2012.

Prior to 2008, Strahlman held senior executive leadership roles in global product development and commercialization, medical affairs and business development at leading pharmaceutical and medical technology companies including Pfizer, Novartis, Virogen, Bausch & Lomb and Merck & Co. She currently serves as a director of Syncona having previously served as a director of Syncona Partners.

At Altria Group, Strahlman will be a member of the finance and innovation committees.　　Enditem